Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Helical intravitreal triamcinolone acetonide implant: a 6-month surgical feasibility study in rabbits.

Mello-Filho PA, Guven D, Beeley NR, de Juan E Jr, Erickson SR.

Ophthalmic Surg Lasers Imaging. 2009 Mar-Apr;40(2):160-8.

PMID:
19320305
2.

Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.

Faghihi H, Taheri A, Farahvash MS, Esfahani MR, Rajabi MT.

Retina. 2008 Oct;28(9):1241-6. doi: 10.1097/IAE.0b013e31817d5be3.

PMID:
18626423
3.

Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device.

Jaffe GJ, Yang CH, Guo H, Denny JP, Lima C, Ashton P.

Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3569-75.

PMID:
11006254
4.

Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.

Berger AS, Cheng CK, Pearson PA, Ashton P, Crooks PA, Cynkowski T, Cynkowska G, Jaffe GJ.

Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2318-25.

PMID:
8843916
5.

Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.

Jaffe GJ, Yang CS, Wang XC, Cousins SW, Gallemore RP, Ashton P.

Ophthalmology. 1998 Jan;105(1):46-56.

PMID:
9442778
6.

Evaluation of triamcinolone acetonide following intravitreal injection in New Zealand white rabbits.

McGee DH, Dembinska O, Gruebbel MM.

Int J Toxicol. 2005 Nov-Dec;24(6):419-25.

PMID:
16393934
7.

Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.

Kamppeter BA, Cej A, Jonas JB.

Ophthalmology. 2008 Aug;115(8):1372-5. doi: 10.1016/j.ophtha.2008.01.019. Epub 2008 Mar 20.

PMID:
18355920
8.

Retinal toxicity of triamcinolone acetonide in silicone-filled eyes.

Kivilcim M, Peyman GA, El-Dessouky ES, Kazi AA, Cheema R, Hegazy H.

Ophthalmic Surg Lasers. 2000 Nov-Dec;31(6):474-8.

PMID:
11095124
9.

Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes.

Oliveira RC, Messias A, Siqueira RC, Bonini-Filho MA, Haddad A, Damico FM, Maia-Filho A, Crispim PT, Saliba JB, Ribeiro JA, Scott IU, Cunha-Jr AS, Jorge R.

Curr Eye Res. 2012 Jan;37(1):55-61. doi: 10.3109/02713683.2011.593722. Epub 2011 Oct 26.

PMID:
22029458
10.

Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis.

Hosseini H, Mehryar M, Eghtedari M, Ahmadi F, Nowroozizadeh S.

Curr Eye Res. 2009 Feb;34(2):145-51. doi: 10.1080/02713680802585938.

PMID:
19219686
11.

Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density.

Kai W, Yanrong J, Xiaoxin L.

Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1152-9. Epub 2006 Feb 2.

PMID:
16453123
12.

A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.

Robinson MR, Lee SS, Kim H, Kim S, Lutz RJ, Galban C, Bungay PM, Yuan P, Wang NS, Kim J, Csaky KG.

Exp Eye Res. 2006 Mar;82(3):479-87. Epub 2005 Sep 15.

PMID:
16168412
13.

Long-term effect on the equine eye of an intravitreal device used for sustained release of cyclosporine A.

Gilger BC, Malok E, Stewart T, Ashton P, Smith T, Jaffe GJ, Allen JB.

Vet Ophthalmol. 2000;3(2-3):105-110.

PMID:
11397291
14.

Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.

Cheng CK, Berger AS, Pearson PA, Ashton P, Jaffe GJ.

Invest Ophthalmol Vis Sci. 1995 Feb;36(2):442-53.

PMID:
7843913
15.

Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.

Konstantinidis L, Berguiga M, Beknazar E, Wolfensberger TJ.

Retina. 2009 Sep;29(8):1119-27. doi: 10.1097/IAE.0b013e3181ac23da.

PMID:
19734764
16.

Development, implantation, in vivo elution, and retrieval of a biocompatible, sustained release subretinal drug delivery system.

Beeley NR, Stewart JM, Tano R, Lawin LR, Chappa RA, Qiu G, Anderson AB, de Juan E, Varner SE.

J Biomed Mater Res A. 2006 Mar 15;76(4):690-8.

PMID:
16302225
17.

Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes.

Albini TA, Abd-El-Barr MM, Carvounis PE, Iyer MN, Lakhanpal RR, Pennesi ME, Chevez-Barrios P, Wu SM, Holz ER.

Invest Ophthalmol Vis Sci. 2007 Jan;48(1):390-5.

PMID:
17197559
18.

Safety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyes.

Fialho SL, RĂªgo MB, Siqueira RC, Jorge R, Haddad A, Rodrigues AL, Maia-Filho A, Silva-Cunha A.

Curr Eye Res. 2006 Jun;31(6):525-34.

PMID:
16769612
19.

[Effect of intravitreal and orbital floor triamcinolone acetonide injection on intraocular inflammation in patients with active non-infectious uveitis].

Roesel M, Gutfleisch M, Heinz C, Heimes B, Zurek-Imhoff B, Heiligenhaus A.

Klin Monbl Augenheilkd. 2009 Feb;226(2):110-4. doi: 10.1055/s-2008-1027762. Epub 2009 Feb 10. German.

PMID:
19206044
20.

Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study.

Yu SY, Damico FM, Viola F, D'Amico DJ, Young LH.

Retina. 2006 May-Jun;26(5):531-6.

Supplemental Content

Support Center